Syed Habib Haider Zaidi1, Rafey A Faruqui. 1. Kemsley, National Centre for Brain Injury Rehabilitation, St Andrew's HealthCare, Northampton, UK. shaider@standrew.co.uk
Abstract
PURPOSE: This report describes the early onset Tardive Dyskinesia like presentation during treatment with Aripiprazole. CASE STUDY: The patient, who had a history of acquired brain injury, was receiving treatment for his psychotic illness characterized by persecutory delusions, second person auditory hallucinations, self-neglect and challenging behaviours. Tardive Dyskinesia is not a well reported side-effect of Aripiprazole. CONCLUSIONS: This report demonstrates onset of this side-effect upon commencement of Aripiprazole and cessation of this side-effect upon termination of this medication. This case report highlights the need for careful monitoring of neurological side-effects in patients with acquired brain injury requiring treatment with anti-psychotic medication.
PURPOSE: This report describes the early onset Tardive Dyskinesia like presentation during treatment with Aripiprazole. CASE STUDY: The patient, who had a history of acquired brain injury, was receiving treatment for his psychotic illness characterized by persecutory delusions, second personauditory hallucinations, self-neglect and challenging behaviours. Tardive Dyskinesia is not a well reported side-effect of Aripiprazole. CONCLUSIONS: This report demonstrates onset of this side-effect upon commencement of Aripiprazole and cessation of this side-effect upon termination of this medication. This case report highlights the need for careful monitoring of neurological side-effects in patients with acquired brain injury requiring treatment with anti-psychotic medication.